World bank lends Tunisia $130 million to finance wheat imports
Reuters
6/29/2022
© Reuters/HAZIR REKA
Albanian Kosovars transport bags of wheat after a harvest in the Kosovo village of Pleshin
TUNIS (Reuters) - The World Bank said on Wednesday it had approved a $130 million loan to Tunisia to finance vital soft wheat imports and provide emergency support to cover barley imports for dairy production.
The loan comes as the North African country suffers a severe financial crisis that has sometimes caused wheat ships to remain anchored in ports for weeks due to its inability to pay.
Video: How the world's major central banks are tackling soaring inflation (CNBC)
-
The Pre-Markets Rundown: August 12, 2022
CNBC -
Drugmakers' shares tumble on growing investor fears over Zantac litigation
CNBC -
Drug stocks under pressure over Zantac litigation concerns
CNBC -
Jim Cramer breaks down drug stocks amid concerns over Zantac litigation
CNBC -
The Chips and Science Act is 'leveling the playing field,' says Micron CEO
CNBC -
A 75 basis point rate hike by the U.S. Fed remains on the table, says advisory firm
CNBC -
Inflation cools in July as CPI data shows general month-over-month steadiness
CNBC -
CapitaLand Investment says it remains confident about China's long-term outlook
CNBC -
Here's why Indians have the highest confidence to travel in Asia-Pacific
CNBC -
Tesla still the clear winner in EVs, says Loup Ventures' Gene Munster
CNBC -
CDC rolls back more Covid guidelines
CNBC -
We need to focus on diversification going forward, says outgoing Marqeta CEO
CNBC -
Digging on on Consumer Price Index numbers
CNBC -
Watch CNBC's full interview with Bob Chapek, Disney CEO
CNBC -
Every deal comes down to shareholder value, says Disney CEO Bob Chapek
CNBC
-
The Pre-Markets Rundown: August 12, 2022 CNBC brings you fast, accurate, and actionable business news and market updates.
CNBC
-
Drugmakers' shares tumble on growing investor fears over Zantac litigation CNBC's Julianna Tatelbaum discusses U.S. litigation focused on heartburn drug Zantac.
-
Drug stocks under pressure over Zantac litigation concerns Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss alleged concerns that Sanofi and GSK's antacid drug Zantac causes cancer.
The central bank said in statement that the loan aims to lessen the impact of the Ukraine war on Tunisia.
(Reporting By Tarek Amara; Editing by Catherine Evans)
Reuters
